CBOA
MBII

Commonwealth Bank of Australia’s Marrone Bio Innovations, Inc. MBII Stock Holding History

Commonwealth Bank of Australia’s Portfolio MBII Stock Details MBII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-110,677
Closed -$294K – 774
2014
Q3 		$294K Buy
110,677
+60,454
+120% +$404K ﹤0.01% 674
2014
Q2 		$584K Buy
+50,223
New +$569K 0.01% 561

Other funds holding MBII

WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
SI
Scout Investments Kansas City, Missouri $3.8B AUM 45.91% 1-Year Est. Return

Commonwealth Bank of Australia's MBII Position: Q4 2014 in Review

Commonwealth Bank of Australia sold out of Marrone Bio Innovations, Inc. (MBII) in Q4 2014, closing a stake of 110,677 shares — an estimated $294K sold.

Commonwealth Bank of Australia first reported a position in MBII in Q2 2014 and held it in 2 quarters. The position peaked at $584K in Q2 2014. 37 funds tracked by Wall St. Rank hold MBII as of Q4 2014.

  • Commonwealth Bank of Australia reported no remaining Marrone Bio Innovations, Inc. position as of Q4 2014 after selling out during the quarter.
  • Commonwealth Bank of Australia sold 110,677 Marrone Bio Innovations, Inc. shares in Q4 2014, an estimated $294K.
  • Commonwealth Bank of Australia first reported a position in Marrone Bio Innovations, Inc. in Q2 2014 and held it in 2 quarters.
  • Commonwealth Bank of Australia's Marrone Bio Innovations, Inc. position peaked at $584K in Q2 2014.
  • 37 funds tracked by Wall St. Rank held Marrone Bio Innovations, Inc. as of Q4 2014.

Based on Commonwealth Bank of Australia's 13F filing for Q4 2014, filed 18 Feb 2015.